Rossignol, Jean-Francois published the artcileA Pilot Clinical Trial of Nitazoxanide in the Treatment of Chronic Hepatitis B, COA of Formula: C12H9N3O5S, the main research area is chronic hepatitis B nitazoxanide.
Chronic infection by the hepatitis B virus (HBV) has remained a major public health problem. To achieve an HBV cure, we will likely need to combine antivirals with different viral targets as well as immunotherapy. Here, we report data from a pilot proof-of-concept clin. trial of nitazoxanide in treating chronic hepatitis B. Conclusion: Nitazoxanide offers novel mechanisms of antiviral activity, and it would be interesting to evaluate the potential of combining nitazoxanide with oral nucleos(t)ide analogs.
Hepatology Communications published new progress about Antiviral agents. 55981-09-4 belongs to class esters-buliding-blocks, name is 2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate, and the molecular formula is C12H9N3O5S, COA of Formula: C12H9N3O5S.
Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics